WebDec 31, 2024 · BDSI markets in U.S.; licensed from Shionogi in April 2024: BUNAVAIL: Treatment of opioid dependence: Approval: U.S. in June 2014: ... Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities … WebMar 22, 2024 · These and other risks are described under the heading "Risk Factors" in our and BDSI’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and other filings with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release.
News Releases BioDelivery Sciences International, Inc.
WebApr 13, 2024 · at BDSI; Search results for "". Search by Keyword. Search by Location Share these Jobs. Results 1 – 25 of 40 Page 1 of 2 « 1; 2 » Search results for "". ... WebFeb 14, 2024 · The news sent shares in BDSI up more than 50% in pre-market trading Monday. The deal, which has been approved by the boards of both companies, was announced earlier in the day, Collegium has... ms word photo collage template
bdsi-20240243 - SEC
WebMar 11, 2024 · Biodelivery Sciences International Inc (BDSI) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2024. Home. SEC Filings. Biodelivery Sciences International Inc (BDSI) 10-K Annual Report Thu Mar 11 2024; SEC Filings. BDSI Valuations. Intrinsic Value. Financial Stability. Financial Ratios. WebMar 22, 2024 · 10-K: BDSI / BioDelivery Sciences International, Inc. FORM 10-K (Annual Report) Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. 2024-03-07: 8-K: Financial … WebMar 10, 2024 · Total operating expenses in the fourth quarter of 2024 were $21.4 million, compared to $23.8 million in Q4 2024 and $22.5 million in Q3 2024. GAAP net income for the fourth quarter was $10.2 ... ms word phamphlet design